KPV
KPV
Tripeptide derived from the C-terminal region of alpha-melanocyte-stimulating hormone
KPV is documented within Alford Molecular Research's Research Compound Library as a tripeptide fragment associated with melanocortin biology. It serves as a laboratory substrate for investigating nonclinical signaling pathways and molecular kinetics in established research models.
Chemical Class
Tripeptide derived from the C-terminal region of alpha-melanocyte-stimulating hormone
Evidence Classification
Preclinical / Mechanistically Plausible
Primary Research Areas
inflammatory signaling, NF-kappaB-associated pathways, intestinal inflammation models, melanocortin-associated biology, epithelial signaling
Molecular Identity
KPV is a tripeptide fragment representing the C-terminal region of alpha-melanocyte-stimulating hormone (alpha-MSH). Within the Alford Molecular Research library, KPV is identified by its specific Lys-Pro-Val sequence. This molecule serves as a specialized research tool for investigating pathways associated with melanocortin biology and peptide-based signaling in nonclinical models. Its origin as a truncated fragment of a larger endogenous hormone allows researchers to isolate signaling dynamics specific to this conserved tripeptide sequence.
Compound
KPV
Chemical Class
Tripeptide derived from the C-terminal region of alpha-melanocyte-stimulating hormone
CAS Number
67727-97-3
Molecular Formula
C16H30N4O4
Average Weight
approximately 342.44 g/mol
Sequence
Lys-Pro-Val
Molecular Target / Mechanism
KPV is investigated for its involvement in inflammatory signaling, NF-kappaB-associated pathways, and melanocortin-associated biology. As a tripeptide derivative of alpha-MSH, it is studied in epithelial signaling systems as a research tool. This data is framed strictly as preclinical and mechanistically plausible research, representing purely experimental inquiry into molecular interactions without any implied therapeutic claims or clinical relevance.
Intracellular Signaling
In scientific documentation, KPV is summarized in relation to intracellular signaling cascades relevant to inflammatory response and epithelial barrier biology. Researchers utilize these models to observe potential regulatory effects on signaling integrity within nonclinical environments. The technical focus remains on verifying the involvement of specific molecular fragments in defined pathway activation, maintaining a rigid research-focused scientific context.
Cellular & Tissue-Level Research
KPV is investigated in preclinical systems to explore its influence on cellular homeostasis and tissue signaling. Research focuses on intestinal inflammation models and epithelial barrier integrity cell systems. These investigations are strictly nonclinical and serve to map mechanistically plausible biological pathways related to alpha-MSH fragments.
Primary Research Areas
Inflammatory Signaling
NF-kappaB Pathways
Mapping the involvement of KPV in pathways associated with NF-kappaB transcriptional regulation.
Intestinal Models
Investigation of molecular cascades involved in systemic and localized signaling integrity.
Studying epithelial barrier performance and signaling in established gut inflammation models.
Melanocortin Biology
Epithelial Signaling
Research into the downstream effects of alpha-MSH fragments on melanocortin-related signaling.
Exploring how the tripeptide sequence interacts with surface markers on epithelial tissue layers.
Translational Research Chain
Molecular Sequence (Lys-Pro-Val)
Mechanistic Pathway Verification
Preclinical Model Assessment
Evidence Classification Registry
Evidence Assessment
KPV is classified as Preclinical / Mechanistically Plausible within the Alford Molecular Research evidence framework. This classification denotes that while significant in vitro and animal model data exist to support its studied mechanisms—particularly regarding NF-kappaB signaling and epithelial integrity—it has not met the threshold for clinical positioning. This assessment is provided for scientific context and does not imply clinical efficacy or safety.
Analytical & Quality-Control Considerations
Structural & Formulation Considerations
- Sequence confirmation by amino acid analysis
- Molecular identity verification by Mass Spectrometry (MS)
- Purity assessment by RP-HPLC (>98% standard)
- Quantitative net peptide content analysis
- Terminal state verification
- Salt/counterion state characterization
- Residual solvent and water content analysis
- Endotoxin and sterility testing where relevant to specific research models
KPV is a highly stable tripeptide in its solid state; however, like all signaling peptides, it is subject to standard degradation pathways in aqueous environments. Research formulations must account for peptide stability concepts such as pH sensitivity and proteolytic susceptibility in cell culture media or tissue homogenates. These parameters are critical for maintaining signaling integrity in preclinical models.
Stability & Handling — Scientific Context
In a laboratory setting, the handling of research peptides requires strict adherence to scientific storage protocols to avoid deamidation or oxidation. High-level scientific context suggests that lyophilized peptides are best maintained at ultra-low temperatures to ensure long-term molecular identity. All handling should occur within controlled laboratory environments to prevent contamination and preserve the net peptide content for quantitative research applications.
RESEARCH CONTEXT NOTICE
KPV is treated as a research-only peptide within Alford Molecular Research's framework. This information is provided for scientific and research context only and is not intended for the treatment, diagnosis, or prevention of any disease. No regulatory approvals are implied, and this compound is not positioned for human use or administration. All research must be conducted within appropriate laboratory and institutional guidelines.